"모더나 백신접종 6~7만원 검토"...美 하루 최다 1천600명 사망 '레드존' 확대<br /><br />The death toll from the coronavirus in the U.S. is quickly approaching 150-thousand with some U.S. states posting record daily fatality numbers.<br />Meanwhile, the biotech, Moderna, which has received nearly 1 billion dollar commitment from the federal government in the U.S. for Covid-19 vaccine development is reportedly seeking to sell the vaccine for 50 to 60 dollars per person.<br />Yoon Jung-min reports.<br />U.S.-based biotech company Moderna has reportedly pitched its COVID-19 vaccine at around 50 to 60 U.S. dollars per course.<br />The Financial Times reported that the price would apply to the U.S. and other high-income countries,... though this is not likely to be final.<br />Currently, Moderna is in Phase 3 of its trial, enlisting 30-thousand participants across the U.S.<br />While Moderna has reportedly suggested a price of over 50 dollars for its vaccine,... other developers, Pfizer and its partner BioNTech, last week agreed with the U.S. a price of 39 dollars per course or a little over 19 dollars per dose.<br />"...They were priced at $19.50, which for a two-dose vaccine will be around a little bit less than $40. Less than what you would pay for many of the flu vaccines."<br />However, Pfizer said Tuesday that other developed countries would not be getting the vaccine at a lower price than what it charges the U.S.<br />On Tuesday alone, the U.S. added almost 16-hundred deaths,... recording the highest daily total in over two months.<br />There were some 60-thousand new infections,... with the total at over 4-point-3 million.<br />In addition, the White House has added three more states to its 'red zone' list,...after reporting more than 100 new cases per 100-thousand people during the past week.<br />With Missouri, North Dakota and Wisconsin added,... the total number of 'red zone' states is now 21.<br />The White House coronavirus task force recommends rolling back the reopening of economic and social activities in those states.<br />Yoon Jung-min, Arirang News.<br />